Selected research
Industry Research
Blue Ear Pig Vaccines Industry Research Report 2026
Market perspective
The global Blue Ear Pig Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Blue Ear Pig Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Blue Ear Pig Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Blue Ear Pig Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Blue Ear Pig Vaccines include CAHIC, Agrovet, Bioveta, Boehringer Ingelheim, CAVAC, Ceva, DHN, Komipharm and MSD Animal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Blue Ear Pig Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (m units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/m units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Blue Ear Pig Vaccines Market by Company
CAHIC
Agrovet
Bioveta
Boehringer Ingelheim
CAVAC
Ceva
DHN
Komipharm
MSD Animal Health
Phibro Animal Health
PULILE
Ringpu Biology
Tecon
WINSUN
ChengDu Tecbond
Sino Pharm
Jinyu Bio-Technology
Qilu Animal
Zoetis
Blue Ear Pig Vaccines Segment by Type
Live Vaccines
Killed Vaccines
Blue Ear Pig Vaccines Segment by Application
Government Tender
Market Sales
Blue Ear Pig Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blue Ear Pig Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blue Ear Pig Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blue Ear Pig Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Blue Ear Pig Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Blue Ear Pig Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Blue Ear Pig Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Live Vaccines
- Killed Vaccines
Applications
- Government Tender
- Market Sales
Companies covered
- CAHIC
- Agrovet
- Bioveta
- Boehringer Ingelheim
- CAVAC
- Ceva
- DHN
- Komipharm
- MSD Animal Health
- Phibro Animal Health
- PULILE
- Ringpu Biology
- Tecon
- WINSUN
- ChengDu Tecbond
- Sino Pharm
- Jinyu Bio-Technology
- Qilu Animal
- Zoetis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Blue Ear Pig Vaccines Market Size (2021-2032)
- 2.2.2 Global Blue Ear Pig Vaccines Sales (2021-2032)
- 2.2.3 Global Blue Ear Pig Vaccines Market Average Price (2021-2032)
- 2.3 Blue Ear Pig Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Live Vaccines
- 2.3.3 Killed Vaccines
- 2.4 Blue Ear Pig Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Government Tender
- 2.4.3 Market Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Blue Ear Pig Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Blue Ear Pig Vaccines Sales (m units) of Manufacturers (2021-2026)
- 3.3 Global Blue Ear Pig Vaccines Revenue of Manufacturers (2021-2026)
- 3.4 Global Blue Ear Pig Vaccines Average Price by Manufacturers (2021-2026)
- 3.5 Global Blue Ear Pig Vaccines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Blue Ear Pig Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Blue Ear Pig Vaccines, Product Type & Application
- 3.8 Global Manufacturers of Blue Ear Pig Vaccines, Established Date
- 3.9 Global Blue Ear Pig Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 CAHIC
- 4.1.1 CAHIC Company Information
- 4.1.2 CAHIC Business Overview
- 4.1.3 CAHIC Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 CAHIC Blue Ear Pig Vaccines Product Portfolio
- 4.1.5 CAHIC Recent Developments
- 4.2 Agrovet
- 4.2.1 Agrovet Company Information
- 4.2.2 Agrovet Business Overview
- 4.2.3 Agrovet Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Agrovet Blue Ear Pig Vaccines Product Portfolio
- 4.2.5 Agrovet Recent Developments
- 4.3 Bioveta
- 4.3.1 Bioveta Company Information
- 4.3.2 Bioveta Business Overview
- 4.3.3 Bioveta Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bioveta Blue Ear Pig Vaccines Product Portfolio
- 4.3.5 Bioveta Recent Developments
- 4.4 Boehringer Ingelheim
- 4.4.1 Boehringer Ingelheim Company Information
- 4.4.2 Boehringer Ingelheim Business Overview
- 4.4.3 Boehringer Ingelheim Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Boehringer Ingelheim Blue Ear Pig Vaccines Product Portfolio
- 4.4.5 Boehringer Ingelheim Recent Developments
- 4.5 CAVAC
- 4.5.1 CAVAC Company Information
- 4.5.2 CAVAC Business Overview
- 4.5.3 CAVAC Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 CAVAC Blue Ear Pig Vaccines Product Portfolio
- 4.5.5 CAVAC Recent Developments
- 4.6 Ceva
- 4.6.1 Ceva Company Information
- 4.6.2 Ceva Business Overview
- 4.6.3 Ceva Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Ceva Blue Ear Pig Vaccines Product Portfolio
- 4.6.5 Ceva Recent Developments
- 4.7 DHN
- 4.7.1 DHN Company Information
- 4.7.2 DHN Business Overview
- 4.7.3 DHN Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 DHN Blue Ear Pig Vaccines Product Portfolio
- 4.7.5 DHN Recent Developments
- 4.8 Komipharm
- 4.8.1 Komipharm Company Information
- 4.8.2 Komipharm Business Overview
- 4.8.3 Komipharm Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Komipharm Blue Ear Pig Vaccines Product Portfolio
- 4.8.5 Komipharm Recent Developments
- 4.9 MSD Animal Health
- 4.9.1 MSD Animal Health Company Information
- 4.9.2 MSD Animal Health Business Overview
- 4.9.3 MSD Animal Health Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 MSD Animal Health Blue Ear Pig Vaccines Product Portfolio
- 4.9.5 MSD Animal Health Recent Developments
- 4.10 Phibro Animal Health
- 4.10.1 Phibro Animal Health Company Information
- 4.10.2 Phibro Animal Health Business Overview
- 4.10.3 Phibro Animal Health Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Phibro Animal Health Blue Ear Pig Vaccines Product Portfolio
- 4.10.5 Phibro Animal Health Recent Developments
- 4.11 PULILE
- 4.11.1 PULILE Company Information
- 4.11.2 PULILE Business Overview
- 4.11.3 PULILE Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 PULILE Blue Ear Pig Vaccines Product Portfolio
- 4.11.5 PULILE Recent Developments
- 4.12 Ringpu Biology
- 4.12.1 Ringpu Biology Company Information
- 4.12.2 Ringpu Biology Business Overview
- 4.12.3 Ringpu Biology Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Ringpu Biology Blue Ear Pig Vaccines Product Portfolio
- 4.12.5 Ringpu Biology Recent Developments
- 4.13 Tecon
- 4.13.1 Tecon Company Information
- 4.13.2 Tecon Business Overview
- 4.13.3 Tecon Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Tecon Blue Ear Pig Vaccines Product Portfolio
- 4.13.5 Tecon Recent Developments
- 4.14 WINSUN
- 4.14.1 WINSUN Company Information
- 4.14.2 WINSUN Business Overview
- 4.14.3 WINSUN Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 WINSUN Blue Ear Pig Vaccines Product Portfolio
- 4.14.5 WINSUN Recent Developments
- 4.15 ChengDu Tecbond
- 4.15.1 ChengDu Tecbond Company Information
- 4.15.2 ChengDu Tecbond Business Overview
- 4.15.3 ChengDu Tecbond Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 ChengDu Tecbond Blue Ear Pig Vaccines Product Portfolio
- 4.15.5 ChengDu Tecbond Recent Developments
- 4.16 Sino Pharm
- 4.16.1 Sino Pharm Company Information
- 4.16.2 Sino Pharm Business Overview
- 4.16.3 Sino Pharm Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Sino Pharm Blue Ear Pig Vaccines Product Portfolio
- 4.16.5 Sino Pharm Recent Developments
- 4.17 Jinyu Bio-Technology
- 4.17.1 Jinyu Bio-Technology Company Information
- 4.17.2 Jinyu Bio-Technology Business Overview
- 4.17.3 Jinyu Bio-Technology Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Jinyu Bio-Technology Blue Ear Pig Vaccines Product Portfolio
- 4.17.5 Jinyu Bio-Technology Recent Developments
- 4.18 Qilu Animal
- 4.18.1 Qilu Animal Company Information
- 4.18.2 Qilu Animal Business Overview
- 4.18.3 Qilu Animal Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Qilu Animal Blue Ear Pig Vaccines Product Portfolio
- 4.18.5 Qilu Animal Recent Developments
- 4.19 Zoetis
- 4.19.1 Zoetis Company Information
- 4.19.2 Zoetis Business Overview
- 4.19.3 Zoetis Blue Ear Pig Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Zoetis Blue Ear Pig Vaccines Product Portfolio
- 4.19.5 Zoetis Recent Developments
5 Global Blue Ear Pig Vaccines Market Scenario by Region
- 5.1 Global Blue Ear Pig Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Blue Ear Pig Vaccines Sales by Region: 2021-2032
- 5.2.1 Global Blue Ear Pig Vaccines Sales by Region: 2021-2026
- 5.2.2 Global Blue Ear Pig Vaccines Sales by Region: 2027-2032
- 5.3 Global Blue Ear Pig Vaccines Revenue by Region: 2021-2032
- 5.3.1 Global Blue Ear Pig Vaccines Revenue by Region: 2021-2026
- 5.3.2 Global Blue Ear Pig Vaccines Revenue by Region: 2027-2032
- 5.4 North America Blue Ear Pig Vaccines Market Facts & Figures by Country
- 5.4.1 North America Blue Ear Pig Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Blue Ear Pig Vaccines Sales by Country (2021-2032)
- 5.4.3 North America Blue Ear Pig Vaccines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Blue Ear Pig Vaccines Market Facts & Figures by Country
- 5.5.1 Europe Blue Ear Pig Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Blue Ear Pig Vaccines Sales by Country (2021-2032)
- 5.5.3 Europe Blue Ear Pig Vaccines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Blue Ear Pig Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific Blue Ear Pig Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Blue Ear Pig Vaccines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Blue Ear Pig Vaccines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Blue Ear Pig Vaccines Market Facts & Figures by Country
- 5.7.1 South America Blue Ear Pig Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Blue Ear Pig Vaccines Sales by Country (2021-2032)
- 5.7.3 South America Blue Ear Pig Vaccines Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Blue Ear Pig Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Blue Ear Pig Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Blue Ear Pig Vaccines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Blue Ear Pig Vaccines Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Blue Ear Pig Vaccines Sales by Type (2021-2032)
- 6.1.1 Global Blue Ear Pig Vaccines Sales by Type (2021-2032) & (m units)
- 6.1.2 Global Blue Ear Pig Vaccines Sales Market Share by Type (2021-2032)
- 6.2 Global Blue Ear Pig Vaccines Revenue by Type (2021-2032)
- 6.2.1 Global Blue Ear Pig Vaccines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Blue Ear Pig Vaccines Revenue Market Share by Type (2021-2032)
- 6.3 Global Blue Ear Pig Vaccines Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Blue Ear Pig Vaccines Sales by Application (2021-2032)
- 7.1.1 Global Blue Ear Pig Vaccines Sales by Application (2021-2032) & (m units)
- 7.1.2 Global Blue Ear Pig Vaccines Sales Market Share by Application (2021-2032)
- 7.2 Global Blue Ear Pig Vaccines Revenue by Application (2021-2032)
- 7.2.1 Global Blue Ear Pig Vaccines Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Blue Ear Pig Vaccines Revenue Market Share by Application (2021-2032)
- 7.3 Global Blue Ear Pig Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Blue Ear Pig Vaccines Value Chain Analysis
- 8.1.1 Blue Ear Pig Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Blue Ear Pig Vaccines Production Mode & Process
- 8.2 Blue Ear Pig Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Blue Ear Pig Vaccines Distributors
- 8.2.3 Blue Ear Pig Vaccines Customers
9 Global Blue Ear Pig Vaccines Analyzing Market Dynamics
- 9.1 Blue Ear Pig Vaccines Industry Trends
- 9.2 Blue Ear Pig Vaccines Industry Drivers
- 9.3 Blue Ear Pig Vaccines Industry Opportunities and Challenges
- 9.4 Blue Ear Pig Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst